Brief: Healius Confirms Receipt Of Off-Market Takeover Bid From Australian Clinical Labs
March 20 (Reuters) - Healius Ltd HLS.AX :
* CONFIRMS RECEIPT OF AN OFF-MARKET TAKEOVER BID FROM
AUSTRALIAN
CLINICAL LABS LIMITED
* BOARD OF HEALIUS ADVISES SHAREHOLDERS TO TAKE NO ACTION IN
RESPECT OF ACL'S TAKEOVER OFFER
Source text for Eikon: ID:nASX9fkYSM
Further company coverage: HLS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Australian Clinical Labs
See all newsBrief: Australian Clinical Labs Appoints Deloitte As Auditor
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australian Clinical Labs falls to over two-week low on trading ex-dividend
Australian Clinical Labs at 6-month high on upbeat full-year results, guidance
Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million